What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.

Senior Managing Director, GE Ventures

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

How a “sticky” consumer experience could help control the drain of high-cost chronic disease drugs.

Partner, Health and Life Sciences, Oliver Wyman

Direct-purchase agreements are being floated as a price-control strategy. But how is value defined? And when might low cost come at the expense of true value?

Partner, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Trendspotting in unpredictable times. This infographic highlights five predictions for 2017.

Managing Partner, Americas, Oliver Wyman
Senior Vice President, Health Care Value, BCBSM

Insights in your inbox

Subscribe

Even amidst the uncertainty of repeal and replace, we see some meaningful trends taking shape. Read our predictions for 2017.

Managing Partner, Americas, Oliver Wyman
Senior Vice President, Health Care Value, BCBSM

Through this series of infographics, learn how payers, providers, and life sciences companies will be impacted by our 45th president.

Global Leader, Health and Life Sciences, Oliver Wyman

A new global report finds female representation is growing on financial services Boards and Executive Committees, but progress is slow.

Senior executives from all areas of healthcare have committed to work collaboratively on key issues impacting consumer value and overall industry sustainability.

With their existing customer base, brand loyalty, physical footprint, and health resources, retailers will play a significant role in offering consumers alternative sites of care.

Principal, Oliver Wyman

Insights in your inbox

Subscribe
Load More